National TV Segment Highlights FDA-Approved Treatment for Rosacea Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET SCOTTSDALE, Ariz., June 09, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatmen ...

Journey Medical Corp (DERM) Q4 2024 Earnings Call March 26, 2025 04:30 PM ET Company Participants Jaclyn Jaffe - Senior Director of Corporate OperationsClaude Maraoui - Co-Founder, President and Chief Executive OfficerJoseph Benesch - CFOLouis Donati - Director - Market AccessSrinivas Sidgiddi - Vice President - Research & DevelopmentBrandon Folkes - Managing Director - Equity Research Conference Call Participants Thomas Flaten - Senior Research AnalystScott Henry - Managing Director & Senior Research Analy ...